ARCHIVES

The Lancet Oncology Retracts Potti Paper, NEJM Doesn’t

This article is from The Cancer Letter archive.

Vol. 37 No. 05 | February 4, 2011

Download PDF Visit The Full Archive

Related Articles

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

Potti Claimed Rhodes Credential in Bio Submitted for DOD Funding

July 30, 2010

DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million

February 27, 1987

NIH Says Its Probe Found Charges Of Double Payment “Basically Correct”

October 23, 1981

Wyden Asks Healy To Clarify CRADA Pricing Clause

January 3, 1992

House Overrides Veto Of Authorization Bill As GOP Members Join Democrats In Assailing Reagan Action

November 15, 1985